https://pipelinereview.com/fda-approves-xeljanz-xr-tofacitinib-extended-release-tablets-for-the-treatment-of-ulcerative-colitis/
FDA Approves XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis